Phosphorex
Contact an Expert
  • About
    • Pathway to Clinical
    • Options for Engagement
    • Leadership and Advisors
  • Drug Delivery Services
    • Targeted Delivery
    • Sustained Release
    • Nucleic Acid Delivery
  • News & Events
    • News
    • Events
  • Learn More
  • Careers
Select Page

Phosphorex Expands Leadership Team: Appoints David Tammaro as Chief Financial Officer

by Jenn McGroary | Jan 17, 2023 | Press Release

Hopkinton, MA, January 17, 2023 – Phosphorex, an Ampersand Capital Partners company, and drug delivery-focused contract development and manufacturing organization (“CDMO”), announced today the appointment of David Tammaro as Chief Financial Officer. David brings over...

Phosphorex Appoints Jarlath Keating as Chief Executive Officer

by tlogan | Sep 19, 2022 | Press Release

Phosphorex Appoints Jarlath Keating as Chief Executive Officer HOPKINTON, Mass., Sept. 19, 2022 /PRNewswire/ — Following the recent growth capital investment from Ampersand Capital Partners, Phosphorex, a drug delivery-focused contract development and...

Phosphorex to Establish cGMP Manufacturing for Lipid Nanoparticles with Growth Capital from Ampersand

by tlogan | Aug 25, 2022 | Press Release

Phosphorex to Establish cGMP Manufacturing for Lipid Nanoparticles with Growth Capital from Ampersand Hopkinton, MA, August 25, 2022 – Phosphorex, a drug delivery-focused contract development and manufacturing organization providing microspheres and polymer and lipid...

Phosphorex and Dolomite Host Collabarative Webinar to Share Their Insights on Making Liposomes and Lipid Nanoparticles (LNPs) with Microfluidics

by tlogan | Feb 16, 2022 | Press Release

Phosphorex and Dolomite Host Collabarative Webinar to Share Their Insights on Making Liposomes and Lipid Nanoparticles (LNPs) with Microfluidics Hopkinton, MA, Feburary 16, 2022 – Phosphorex & Dolomite experts Dr. Julia Rashba-Step, Dr. Cate O’Brien, Dr. Nicholas...

Phosphorex and Dolomite Jointly Publish Articles to Discuss How Automation Benefits Development and Production of Lipid Nanoparticles (LNPs)

by tlogan | Aug 11, 2021 | Article, Press Release

Phosphorex and Dolomite Jointly Publish Articles to Discuss How Automation Benefits Development and Production of Lipid Nanoparticles (LNPs) Hopkinton, MA, August 11, 2021 – Dr. Julia Rashba-Step, Phosphorex’ Vice President of R&D and Alliance Management,...
« Older Entries

Recent Comments

    Phosphorex, LLC
    35 Parkwood Drive
    Suite 210
    Hopkinton, MA 01748

    Phone 508 435-9100
    Toll Free 877 288-8010
    Fax 508 435-9109

    Email
    info@phosphorex.com
    email for collaborators
    bd@phosphorex.com

    COPYRIGHT © 2023 PHOSPHOREX, LLC · ALL RIGHTS RESERVED